EDGAR Filing Documents for 0001437749-16-038645

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001437749-16-038645

Filing Date

2016-09-13

Accepted

2016-09-13 17:14:35

Documents

Period of Report

2016-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	bota20160630_10k.htm	10-K	2138867
2	EXHIBIT 3.1	ex3-1.htm	EX-3.1	135954
3	EXHIBIT 3.2	ex3-2.htm	EX-3.2	112974
4	EXHIBIT 21.1	ex21-1.htm	EX-21.1	3028
5	EXHIBIT 23.1	ex23-1.htm	EX-23.1	9475
6	EXHIBIT 23.1A	ex23-1a.htm	EX-23.1A	3349
7	EXHIBIT 31.1	ex31-1.htm	EX-31.1	10379
8	EXHIBIT 31.2	ex31-2.htm	EX-31.2	10374
9	EXHIBIT 32.1	ex32-1.htm	EX-32.1	5300
10	EXHIBIT 32.2	ex32-2.htm	EX-32.2	4507
17		a1.jpg	GRAPHIC	62665
18		hrv.jpg	GRAPHIC	38765
19		debt.jpg	GRAPHIC	63049
	Complete submission text file	0001437749-16-038645.txt		8631406

Data Files

Seq	Description	Document	Type	Size
11	EXHIBIT 101.INS	avir-20160630.xml	EX-101.INS	1641093
12	EXHIBIT 101.SCH	avir-20160630.xsd	EX-101.SCH	68811
13	EXHIBIT 101.CAL	avir-20160630_cal.xml	EX-101.CAL	68024
14	EXHIBIT 101.DEF	avir-20160630_def.xml	EX-101.DEF	475115
15	EXHIBIT 101.LAB	avir-20160630_lab.xml	EX-101.LAB	400268
16	EXHIBIT 101.PRE	avir-20160630_pre.xml	EX-101.PRE	511681

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009

Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099

Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)